Study Group: Political Experts (outside Washington DC)(?)
Council Members in this Study Group: 700
Request a survey with this Study Group
Leading Experts in this Study Group
![]() |
What is a GLG Leader? |
Paul EqualePrincipal
EQUALE AND ASSOCIATES
Paul Equale is the President of Equale & Associates, where he consults on financial services issues, including credit cards, subprime mortgages, GSEs Fannie Mae/Freddie Mac, online gaming, state, federal legislative and regulatory insurance issues, as well as domestic and international political and...
Jeff StierAssociate Director
American Council on Science and Health
Jeff Stier is an Associate Director at the American Council on Science and Health, a public health and consumer advocacy organization dedicated to promoting sound science in public health. In this position, he is responsible for government relations, policy, legal affairs and development. Mr. Stier...
Principal
THE OUTLAW GROUP
Deborah Outlaw is the Principal of The Outlaw Group in Washington, DC, where she provides legislative, regulatory and medical coding services to physician specialty groups, allied health providers, medical device manufacturers, and non-profit organizations interested in medical research. With over 25...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Experts(?)
Billions of dollars in pharmaceutical revenue, a large chunk of the advertising industry, and public health implications are at stake as Congress once again considers stricter limits on direct to consumer (DTC) advertising.
Allowing "generic" versions of biotech drugs to market without full safety testing would endanger consumers
The decision on medical devices is good news for pharmaceuticals. If medicines get the same protection -- it could bode well -- for reasons beyond the obvious.
A proposed regulatory change proposed on the Friday before a holiday weekend could have a major impact on pharmaceutical profits (and consumer health).
This bill can significantly impact commerce. Product liability and the ability to import products from developing countries may be acutely affected. Analysis includes not only who the bill hurts, but who it may help.
GLG InstituteSM
Seminars with this Study Group's Leaders(?)
Recent Seminars
Most Common Company Types:
- Academic Institution*
- Lobbying Firm
- Policy or Political Consulting Firm
- Advocacy Group or Issue Focused
- Law Firm (general practice/large)
- Think Tank
- Professional or Industry Association*
Most Common Job Types:
- Professor
- Assistant Professor
- Director
- Lobbyist
- Partner
- Principal
- President
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms


